Moxifloxacin for Buruli ulcer/HIV coinfected patients: kill two birds with one stone?
AffiliationaManson Unit, Médecins Sans Frontières, London, UK bDepartment of Infectious Diseases, Geelong Hospital, Geelong cDepartment of Medicine and Infectious Diseases, Royal Melbourne Hospital, University of Melbourne, Melbourne, Australia dMedical Unit, Médecins Sans Frontières, Geneva, Switzerland eCenter for Infectious Diseases Epidemiology Research, University of Cape Town, Cape Town, South Africa fDepartment of HIV, University Hospitals of Geneva, Geneva, Switzerland.
MetadataShow full item record
- Moxifloxacin for Buruli ulcer/HIV-coinfected patients: kill two birds with one stone? Author reply.
- Authors: O'Brien DP, Comte E, Ford N, Christinet V, Du Cros P
- Issue date: 2014 Jul 31
- Oral treatment for patients with Buruli ulcer co-infected with HIV: think twice.
- Authors: Klis S, van der Werf TS, Phillips RO, Sarfo FS, Wansbrough-Jones M, Stienstra Y
- Issue date: 2014 Mar 13
- Moxifloxacin for the treatment of HIV-associated tuberculosis in patients with contraindications or intolerance to rifamycins.
- Authors: Bonora S, Mondo A, Trentini L, Calcagno A, Lucchini A, Di Perri G
- Issue date: 2008 Jul
- [Moxifloxacin (Kanavig), ophthalmic administration].
- Issue date: 2012 Jun
- Challenges Associated with Management of Buruli Ulcer/Human Immunodeficiency Virus Coinfection in a Treatment Center in Ghana: A Case Series Study.
- Authors: Tuffour J, Owusu-Mireku E, Ruf MT, Aboagye S, Kpeli G, Akuoku V, Pereko J, Paintsil A, Bonney K, Ampofo W, Pluschke G, Yeboah-Manu D
- Issue date: 2015 Aug